232 related articles for article (PubMed ID: 9221806)
1. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas.
Hammel PR; Forgue-Lafitte ME; Lévy P; Voitot H; Vilgrain V; Fléjou JF; Molas G; Gespach C; Ruszniewski P; Bernades P; Bara J
Int J Cancer; 1997 Jun; 74(3):286-90. PubMed ID: 9221806
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions.
Hammel P; Voitot H; Vilgrain V; Lévy P; Ruszniewski P; Bernades P
Eur J Gastroenterol Hepatol; 1998 Apr; 10(4):345-8. PubMed ID: 9855052
[TBL] [Abstract][Full Text] [Related]
3. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
[TBL] [Abstract][Full Text] [Related]
4. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
[TBL] [Abstract][Full Text] [Related]
6. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
Linder JD; Geenen JE; Catalano MF
Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
[TBL] [Abstract][Full Text] [Related]
8. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.
O'Toole D; Palazzo L; Hammel P; Ben Yaghlene L; Couvelard A; Felce-Dachez M; Fabre M; Dancour A; Aubert A; Sauvanet A; Maire F; Lévy P; Ruszniewski P
Gastrointest Endosc; 2004 Jun; 59(7):823-9. PubMed ID: 15173795
[TBL] [Abstract][Full Text] [Related]
9. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
10. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
[TBL] [Abstract][Full Text] [Related]
11. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
12. The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia.
Shami VM; Sundaram V; Stelow EB; Conaway M; Moskaluk CA; White GE; Adams RB; Yeaton P; Kahaleh M
Pancreas; 2007 May; 34(4):466-9. PubMed ID: 17446847
[TBL] [Abstract][Full Text] [Related]
13. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions.
Centeno BA; Lewandrowski KB; Warshaw AL; Compton CC; Southern JF
Am J Clin Pathol; 1994 Apr; 101(4):483-7. PubMed ID: 8160642
[TBL] [Abstract][Full Text] [Related]
14. Investigation of gonadal markers in cystic pancreatic lesions: a pilot study.
Gorman D; Wong RF; Hilden K; Adler DG
Minerva Gastroenterol Dietol; 2011 Mar; 57(1):105-6. PubMed ID: 21372775
[No Abstract] [Full Text] [Related]
15. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
[TBL] [Abstract][Full Text] [Related]
17. Pseudocyst of the pancreas: the role of cytology and special stains for mucin.
Gonzalez Obeso E; Murphy E; Brugge W; Deshpande V
Cancer; 2009 Apr; 117(2):101-7. PubMed ID: 19365837
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cystic lesions without overt cytologic atypia: proposed diagnostic categories for endoscopic ultrasound-guided fine-needle aspiration cytology with utilization of fluid carcinoembryonic antigen level.
Madan R; Khan E; Cuka N; Olyaee M; Tawfik O; Fan F
Acta Cytol; 2012; 56(1):34-40. PubMed ID: 22236743
[TBL] [Abstract][Full Text] [Related]
20. Cystic fluid chromogranin A levels in different pancreatic cystic lesions.
Oruç N; Aydın A; Barutcuoğlu B; Aktan Ç; Nart D; Veral A
Turk J Gastroenterol; 2015 Nov; 26(6):522-7. PubMed ID: 26510084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
